Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionIntracranial atherosclerosis‐related large vessel occlusion (ICAS‐LVO) is a common cause of failed mechanical thrombectomy (MT) in acute ischemic stroke (AIS) [1]. Our survey underscores the need for future research and randomized clinical trials to address the uncertainties in the management of ICAS‐LVO during MT.

Atherosclerosis 40

Atherosclerosis Angioplasty Biomarkers Stent 40

Open Heart

MARCH 24, 2023

This advancement from the ‘wear and tear’ model is a result of the growing economic and health burden of AS, particularly within industrialised countries, prompting further research. The pathophysiology of calcific AS (CAS) is complex, yet can be characterised similarly to that of atherosclerosis.

Stenosis 52

Stenosis Aortic Aortic valve Biomarkers 52

Cardiometabolic Health Congress

OCTOBER 25, 2024

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease.

CME 64

CME Innovation Education Atherosclerosis 64

European Journal of Heart Failure

NOVEMBER 3, 2024

Aims Abnormalities in specific echocardiographic parameters and cardiac biomarkers have been reported among individuals with diabetes. In this study, we developed and validated a machine learning-based clustering approach to identify the high-risk DbCM phenotype based on echocardiographic and cardiac biomarker parameters.

Cardiomyopathy 40

Cardiomyopathy Diabetes Biomarkers Atherosclerosis 40

Dr. Paddy Barrett

SEPTEMBER 19, 2023

We now have more than an additional decade of research on what the impact of statin therapy and aggressive cholesterol-lowering might have on cognitive function. Additionally, access to cholesterol synthesis biomarker testing, including desmosterol and lathosterol levels, can be challenging to obtain. Atherosclerosis.

Dementia 52

Dementia Cholesterol Biomarkers Coronary Artery Disease 52

DAIC

DECEMBER 13, 2023

MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEART ATTACKS, STROKES AND CORONARY ARTERY DISEASE. THE UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE'S CLINT L.

Heart attacks 105

Heart attacks Heart Attack Atherosclerosis Stroke 105

DAIC

JANUARY 30, 2024

The new model uses a set of 10 factors including age, cigarette smoking status, diabetes status, and blood levels of several cardiac biomarkers, to gauge the risk of a new cardiovascular event, regardless of whether the patient has had one before. Parameters of the new model are available in the paper supplements.

Cardiovascular Disease 52

Cardiovascular Disease Research Heart Attack Heart attacks 52

DAIC

FEBRUARY 1, 2024

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. percent Compound Annual Growth Rate (CAGR).

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Peripheral Arterial Disease Stroke 104

DAIC

JANUARY 23, 2024

1,6 Until recently atherosclerosis has been thought of as the result of passive lipid accumulation in the vessel wall. However, the development of atherosclerosis is now known to be much more complex, with a key role for immune cells and inflammation in conjunction with hyperlipidemia and elevated LDL levels.7

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Stroke Journal

JANUARY 30, 2025

Future research should investigate the bidirectionality of this relationship, particularly in the context of acute ischemic injury, focusing on the shared mechanisms of renal and neurovascular dysfunction to develop more effective prevention and therapeutic strategies aimed at reducing the burden of disease in our aging population.

Atherosclerosis 40

Atherosclerosis Kidney Disease Blood Pressure Biomarkers 40

Cardiometabolic Health Congress

AUGUST 8, 2024

Subscribe below to stay informed on the latest research and innovations in cardiometabolic care, including collaboration and partnership insights, ensuring you can seamlessly integrate these strategies into your practice. Key contributions: Advanced cardiac imaging (e.g., Key contributions: Advanced cardiac imaging (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Physiologically Speaking

MAY 17, 2024

Most of the evidence on the harms of extreme exercise is related to a biomarker of cardiovascular disease known as coronary artery calcification or CAC. Exercise and Coronary Atherosclerosis | Circulation What’s lacking, however, is good data on long-term survival and lifespan among “extreme exercisers.” years and 4.1

Physiology 98

Physiology Exercise Biomarkers Cardiovascular Disease 98

Physiologically Speaking

APRIL 24, 2024

The amount of calcium in the blood vessels (known as arterial calcification), a marker of subclinical atherosclerosis, is higher in people with a short sleep duration. 14 One study of over 1,900 men found evidence that very short sleep duration predicts a higher burden of atherosclerosis in their coronary and femoral arteries.

Blood Pressure 52

Blood Pressure Blood Clot COVID-19 Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

NOVEMBER 25, 2024

In this investigation, our objective is to establish computational models elucidating molecular-level markers associated with atherosclerosis. Nevertheless, our current understanding of its pathogenesis remains imprecise.

Atherosclerosis 59

Atherosclerosis Biomarkers Plaque Hypertension 59

Frontiers in Cardiovascular Medicine

NOVEMBER 29, 2024

Studies have shown that patients with gout are more likely to develop atherosclerosis, but the specific mechanisms involved remain unknown. The receiver operating characteristic (ROC) curves showed that the areas under ROC curve (AUC) for these four key genes in both gout and atherosclerosis were greater than 0.9.

Atherosclerosis 45

Atherosclerosis Biomarkers Research 45

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2025

This research explored the therapeutic effects and potential mechanisms of Ligustrum vicaryi L. Analysis indicated that the 9 hub genes (AKT1, HSP90AA1, SRC, GSK3, VEGFR2, RHOA, ENO1, PKM, and IL-2) play roles in MF treatment by participating in signaling pathways related to prostate cancer, lipid and atherosclerosis, and insulin resistance.

Pharmacology 40

Pharmacology Atherosclerosis Biomarkers Cancer 40

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME 103

CME Obesity Heart Failure Biomarkers 103